Because DNA damage repair is one of the main mechanisms that affects the efficacy of chemotherapy, to define a mechanism of action for mutp53 in the response to ADR, we first compared the differences in DNA damage between p53 wt vs. p53 mut-type BrCa cells. This evidence concerns the gene TP53 and invasive breast carcinoma.